FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to medicine and pharmaceutics and can be used for prevention and treatment of asthenozoospermia and teratozoospermia. For this purpose, it is proposed to apply Verva fir extract in an effective dose once a day daily for 5 days before and 5 days after cytostatic exposure as an agent for prevention and treatment of asthenozoospermia and teratozoospermia.
EFFECT: invention provides higher sperm cell mobility and reduced number of pathological forms in asthenozoospermia and teratozoospermia.
1 cl, 1 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR PATHOZOOSPERMIA PREVENTION AND TREATMENT | 2016 |
|
RU2619330C1 |
| AGENT HAVING CANCER-PREVENTIVE ACTION ON TESTICULAR CANCER AND HEREDITARY CANCER | 2023 |
|
RU2820551C1 |
| MEANS FOR PREVENTING AND CORRECTING SPERMATOGENESIS DISORDERS CAUSED BY CYTOSTATIC TREATMENT | 2006 |
|
RU2318529C1 |
| MEANS FOR CORRECTION OF PATHOLOGIC CHANGES OF VIABLE OFFSPRING, CAUSED BY CYTOSTATIC IMPACT ON MOTHER'S ORGANISM | 2014 |
|
RU2552612C1 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT FOR STIMULATING TISSUE REGENERATION AND RECOVERY OF DIMINISHED TISSUE FUNCTION | 2015 |
|
RU2647438C2 |
| MEANS AND METHOD FOR IMPROVING SPERM QUALITY | 1999 |
|
RU2159122C1 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT STIMULATING TISSUE REGENERATION AND RESTORATION OF REDUCED FUNCTIONS OF TISSUES | 2016 |
|
RU2727142C2 |
| MEANS FOR CORRECTION OF OVARY DAMAGE CAUSED BY CYTOSTATIC EFFECT | 2021 |
|
RU2785397C1 |
| USE OF OXIDISED DEXTRAN FOR TREATING AND PREVENTING INFECTIOUS-INFLAMMATORY DISORDERS OF SPERMATOGENESIS | 2023 |
|
RU2814617C1 |
| AGENT EXHIBITING WITH DETOXIFYING ACTIVITY IN ALCOHOL INTOXICATION | 2021 |
|
RU2787997C1 |
